Guidelines

New and updated guidelines

1. Dec. 1, 2026 · EASL

   EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy

   The joint EASL-EASD-EASO guidance recommends resmetirom or semaglutide for adults with non-cirrhotic MASH and fibrosis stages 2-3, alongside lifestyle intervention and optimized comorbidity management. It addresses treatment selection, initiation, monitoring, and discontinuation, and advises against using these agents as MASH-targeted therapy in adults with MASH cirrhosis until further data are available.

   Source: EASL (opens in a new tab)

2. Sept. 30, 2026 · AGA

   AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular…

   The AGA advises individualized decisions about pancreatic cyst and hepatocellular carcinoma surveillance in older adults, considering comorbidities, life expectancy, risks, and treatment candidacy. It recommends considering when to stop surveillance through shared decision-making.

   Source: AGA (opens in a new tab)

3. Sept. 30, 2026 · ACC/AHA

   2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management…

   The ACC/AHA guideline recommends approaches to perioperative cardiovascular evaluation and management for adults undergoing noncardiac surgery, including pharmacological therapies, monitoring, and devices for cardiovascular disease and associated conditions.

   Source: ACC/AHA (opens in a new tab)

4. Sept. 28, 2026 · AAP

   Clinical Practice Guideline for the Diagnosis and Treatment of Urinary Tract Infection in Children…

   The AAP guideline provides recommendations for diagnosing and managing urinary tract infections in children 8 days to 5 years of age with low medical complexity. It covers medical evaluation, antibiotic treatment, imaging, prevention strategies, and evaluation and treatment of bowel and bladder dysfunction.

   Source: AAP (opens in a new tab)

5. Sept. 28, 2026 · ACC/AHA

   2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management…

   The ACC/AHA guideline recommends approaches to perioperative cardiovascular evaluation and management for adults undergoing noncardiac surgery, including evidence-based strategies for cardiovascular disease and associated conditions.

   Source: ACC/AHA (opens in a new tab)

6. Sept. 22, 2026 · VA/DoD

   Tobacco Use Treatment: Synopsis of the 2026 U.S. Department of Veterans Affairs and U.S. Department…

   The 2026 VA/DoD guideline recommends motivational interviewing and FDA-approved pharmacotherapies to increase abstinence from combustible tobacco, with varenicline preferred over other single-agent medications and combination NRT preferred over NRT alone. It also addresses treatment for smokeless tobacco, electronic nicotine delivery systems, and patients not ready to quit within 30 days.

   Source: VA/DoD (opens in a new tab)